Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EXAS EXACT Sciences Corporation

-0.87 (-2.04%)
Jun 14 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 1,950,468
Bid Price 41.30
Ask Price 42.44
News -
Day High 42.97


52 Week Range


Day Low 41.20
Company Name Stock Ticker Symbol Market Type
EXACT Sciences Corporation EXAS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.87 -2.04% 41.88 20:00:00
Open Price Low Price High Price Close Price Prev Close
42.44 41.20 42.97 41.88 42.75
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
24,096 1,950,468 $ 41.85 $ 81,629,313 - 41.20 - 100.77
Last Trade Time Type Quantity Stock Price Currency
19:58:29 1 $ 42.00 USD

EXACT Sciences (EXAS) Options Flow Summary

Overall Flow


Net Premium


Calls / Puts


Buys / Sells




Sweeps Ratio


EXACT Sciences Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
7.61B 181.53M - 2.58B -204.15M -1.12 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

EXACT Sciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No EXAS Message Board. Create One! See More Posts on EXAS Message Board See More Message Board Posts

Historical EXAS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week43.8044.2741.2042.532,172,891-1.92-4.38%
1 Month52.0554.7941.2047.763,101,119-10.17-19.54%
3 Months62.3779.6241.2058.583,095,511-20.49-32.85%
6 Months69.6879.6241.2060.902,515,636-27.80-39.90%
1 Year92.73100.7741.2067.061,999,254-50.85-54.84%
3 Years123.14133.9929.2765.782,000,982-81.26-65.99%
5 Years112.24159.5429.2779.051,941,164-70.36-62.69%

EXACT Sciences Description

Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a non-invasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a genetic-based treatment selection test for breast, prostate, and colon cancers. With the acquisitions of Base Genomics and Thrive Earlier Detection, Exact is building a multi-cancer early screening test to detect over 14 cancers, a test that would be one of earliest entrants in multi-cancer liquid biopsy cancer screening.

Your Recent History

Delayed Upgrade Clock